|
Resolution: standard / high Figure 2.
Canonical and non-canonical (Abl) Notch signaling pathways. A, co-activator; CSL, CBF, Su(H), Lag3; DSL, Delta, Serrate, Lag2; R, co-repressor;
S1, S2, S3 and S4, Notch cleavage sites in the canonical signaling pathway; TACE,
tumor necrosis factor alpha converting enzyme.
Sassi et al. Arthritis Research & Therapy 2011 13:208 doi:10.1186/ar3255 |